Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medcli.2024.12.007 | DOI Listing |
Med Clin (Barc)
January 2025
Unidad de Medicina Pleural y Ecografía Clínica, Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, IRBLleida, Lleida, España. Electronic address:
Can Fam Physician
January 2025
Vice-Chair of Quality and Innovation in the DFCM at U of T; Associate Professor in the Faculty of Medicine and the Institute of Health Policy, Management and Evaluation at U of T; Scientist in the MAP Centre for Urban Health Solutions at St Michael's Hospital; and a staff physician in the DFCM at St Michael's Hospital, Unity Health Toronto.
Objective: To understand the role of primary care in the COVID-19 pandemic to provide insight into its functioning and inform potential reforms.
Composition Of The Committee: The now dissolved Ontario COVID-19 Science Advisory Table (Science Table) was formed in July 2020 to provide decision makers and the public with a synthesis of rapidly evolving evidence related to COVID-19. The Science Table was based at the Dalla Lana School of Public Health at the University of Toronto, and supported by Public Health Ontario.
Thromb Haemost
January 2025
Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.
The McMaster Immune Thrombocytopenia (ITP) Summit, held on October 27, 2023, was an educational seminar from leading experts in immune thrombocytopenia and related disorders geared toward hematologists, internists, immunologists, and clinical and translational scientists. The focus of the Summit was to review the mechanisms, diagnosis, and treatment of primary versus secondary ITP. Specific objectives were to describe the unique features of secondary ITP, and to review its mechanisms in the context of autoimmune disease and infection.
View Article and Find Full Text PDFMed Decis Making
February 2025
University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Background: After a new drug or medical device is approved by the US Food and Drug Administration (FDA), physician-patient communication about benefits and risks is critical, including whether the product was approved through an expedited pathway based on limited evidence. In addition, physician reporting of drug- and device-related adverse events in real-world use is necessary to have a complete safety profile. We studied physician-reported communication and safety-reporting practices related to drugs and devices.
View Article and Find Full Text PDFEur J Intern Med
November 2024
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!